Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug

Colloids and Surfaces B: Biointerfaces

Volumn 88, Issue 1, 2011, Pages 158-164

  Kuo, Yung Chih ^a   Yu, Hsin Wei ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Drug release; Poly(lactide co glycolide); Poly ( glutamic acid); Polyethyleneimine; Saquinavir

Indexed keywords

ANTIRETROVIRAL DRUGS; ANTIRETROVIRALS; DIMETHYLAMMONIUM; DISSOLUTION RATES; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENTRAPMENT EFFICIENCY; GLUTAMIC ACID; GRAFTING EFFICIENCY; LACTIDES; MORPHOLOGICAL IMAGES; PARTICLE DIAMETERS; POLY LACTIDE-CO-GLYCOLIDE; POLYETHYLENEIMINE; SAQUINAVIR; WEIGHT PERCENTAGES;

BROMINE COMPOUNDS; DISSOLUTION; DRUG DELIVERY; EFFICIENCY; GRAFTING (CHEMICAL); NANOPARTICLES;

AMINO ACIDS;

DIDODECYLDIMETHYLAMMONIUM BROMIDE; DRUG CARRIER; NANOPARTICLE; POLY(GAMMA GLUTAMIC ACID); POLYETHYLENEIMINE; POLYGLACTIN; SAQUINAVIR; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL EFFECTIVENESS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHOBICITY; MOLECULAR WEIGHT; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ANTI-RETROVIRAL AGENTS; DRUG CARRIERS; LACTIC ACID; MODELS, CHEMICAL; NANOPARTICLES; POLYETHYLENEIMINE; POLYGLUTAMIC ACID; POLYGLYCOLIC ACID;

EID: 80052083565     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.06.026     Document Type: Article

References (42)

1. Mugavero M.J., Hicks C.B. HIV resistance and the effectiveness of combination antiretroviral treatment. Drug Discov. Today Ther. Strateg. 2004, 1:529-535.
2. Kuo Y.C., Su F.L. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. Int. J. Pharm. 2007, 340:143-152.
3. Brasnjevic I., Steinbusch H.W., Schmitz C., Martinez P.M. Delivery of peptide and protein drugs over the blood-brain barrier. Prog. Neurobiol. 2009, 87:212-251.
4. Kuo Y.C., Chung C.Y. Transport of zidovudine- and lamivudine-loaded polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate nanoparticles across the in vitro blood-brain barrier: characteristics of the drug-delivery system. J. Chin. Inst. Chem. Eng. 2005, 36:627-638.
5. Vorbrodt A.W. Ultracytochemical characterization of anionic sites in the wall of brain capillaries. J. Neurocytol. 1989, 18:359-368.
6. Béduneau A., Saulnier P., Benoit J.P. Active targeting of brain tumors using nanocarriers. Biomaterials 2007, 28:4947-4967.
7. Gabathuler R. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol. Dis. 2010, 37:48-57.
8. Tsuji A., Tamai I. Carrier-mediated or specialized transport of drugs across the blood-brain barrier. Adv. Drug Deliv. Rev. 1999, 36:277-290.
9. Abbott N.J. Prediction of blood-brain barrier permeation in drug discovery from in vivo, in vitro and in silico models. Drug Discov. Today Technol. 2004, 1:407-416.
10. Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010, 37:13-25.
11. Y.C. Kuo, P.I. Lin, C.C. Wang, Targeting nevirapine delivery across human brain microvesscular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles, Nanomedicine, in press, doi:10.2217/nnm.11.25.
12. Shih I.L., Van Y.T. The production of poly(γ-glutamic acid) from microorganisms and its various applications. Bioresour. Technol. 2001, 79:207-225.
13. Akagi T., Kaneko T., Kida T., Akashi M. Preparation and characterization of biodegradable nanoparticles based on poly(g-glutamic acid) with l-phenylalanine as a protein carrier. J. Control. Release 2005, 108:226-236.
14. Yoshikawa T., Okada N., Oda A., Matsuo K., Matsuo K., Kayamuro H., Ishii Y., Yoshinaga T., Akagi T., Akashi M., Nakagawa S. Nanoparticles built by self-assembly of amphiphilic γ-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells. Vaccine 2008, 26:1303-1313.
15. Okamoto S., Matsuura M., Akagi T., Akashi M., Tanimoto T., Ishikawa T., Takahashi M., Yamanishi K., Mori Y. Poly(glutamic acid) nanoparticles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. Vaccine 2009, 27:5896-5905.
16. Peng S.F., Yang M.J., Su C.J., Chen H.L., Lee P.W., Wei M.C., Sung H.W. Effects of incorporation of poly(γ-glutamic acid) in chitosan/DNA complex nanoparticles on cellular uptake and transfection efficiency. Biomaterials 2009, 30:1797-1808.
17. Markland P., Amidon G.L., Yang V.C. Modified polypeptides containing γ-benzyl glutamic acid as drug delivery platforms. Int. J. Pharm. 1999, 178:183-192.
18. Vancha A.R., Govindaraju S., Parsa K.V., Jasti M., Gonzalez-Garcia M., Ballestero R.P. Use of polyethyleneimine polymer in cell culture as attachment factor and lipofection enhancer. BMC Biotechnol. 2004, 4:23-34.
19. Bledi Y., Domb A.J., Linial M. Culturing neuronal cells on surfaces coated by a novel polyethyleneimine-based polymer. Brain Res. Protoc. 2004, 20:1797-1801.
20. Lakard S., Herlem G., Propper A., Hastner A., Michel G., Valles-Villarreal N., Gharbi T., Fahys B. Adhesion and proliferation of cells on new polymers modified biomaterials. Bioelectrochemistry 2004, 62:19-27.
21. Kuo Y.C., Ku I.N. Application of polyethyleneimine-modified scaffolds to the regeneration of cartilaginous tissue. Biotechnol. Prog. 2009, 25:1459-1467.
22. Yallapu M.M., Jaggi M., Chauhan S.C. Design and engineering of nanogels for cancer treatment. Drug Discov. Today 2011, 16:457-463.
23. Kreuter J. Application of nanoparticles for the delivery of drugs to the brain. Int. Congr. Ser. 2005, 1277:85-94.
24. Kuo Y.C., Chen H.H. Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells. J. Drug Target. 2010, 18:447-456.
25. Acharya S., Sahoo S.K. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv. Drug Deliv. Rev. 2011, 63:170-183.
26. Kuo Y.C., Liang C.T. Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells. Colloids Surf. B 2011, 85:131-137.
27. Li C. Poly(l-glutamic acid)-anticancer drug conjugates. Adv. Drug Deliv. Rev. 2002, 54:695-713.
28. Berry G.C. Thermodynamic and conformational properties of polystyrene. II. Intrinsic viscosity studies on dilute solutions of linear polystyrenes. J. Phys. Chem. 1967, 46:1338-1352.
29. Togrul H., Arslan N. Flow properties of sugar beet pulp cellulose and intrinsic viscosity-molecular weight relationship. Carbohydr. Polym. 2003, 54:63-71.
30. Kuo Y.C. Loading efficiency of stavudine on polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticles. Int. J. Pharm. 2005, 290:161-172.
31. Kuo Y.C., Yeh C.F., Yang J.T. Differentiation of bone marrow stromal cells in poly(lactide-co-glycolide)/chitosan scaffolds. Biomaterials 2009, 30:6604-6613.
32. Kuo Y.C., Yu H.W. Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles. Colloids Surf. B 2011, 84:253-258.
33. Kuo Y.C., Chung J.F. Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Colloids Surf. B 2011, 83:299-306.
34. Makino K., Yamamoto S., Fujimoto K., Kawaguchi H., Ohshima H. Surface structure of latex particles covered with temperature-sensitive hydrogel layers. J. Colloid Interface Sci. 1994, 166:251-258.
35. Kuo Y.C., Lin S.C. Effect of glutamate on the electrical properties of cationic solid lipid nanoparticles containing stearylamine and dioctadecyldimethyl ammonium bromide. J. Phys. Chem. B 2008, 112:4454-4460.
36. Kuo Y.C., Chiu K.H. Inverted colloidal crystal scaffolds with laminin-derived peptides for neuronal differentiation of bone marrow stromal cells. Biomaterials 2011, 32:819-831.
37. Kuo Y.C., Chen H.H. Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. Int. J. Pharm. 2009, 365:206-213.
38. Kuo Y.C., Wang C.C. Electrophoresis of human brain microvascular endothelial cells with uptake of cationic solid lipid nanoparticles: effect of surfactant composition. Colloids Surf. B 2010, 76:286-291.
39. Kuo Y.C. Deposition of cation-absorptive biocolloids onto a charged surface. J. Colloid Interface Sci. 2005, 288:36-44.
40. Kuo Y.C., Liang C.T. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor. Biomaterials 2011, 32:3340-3350.
41. Zolnik B.S., Leary P.E., Burgess D.J. Elevated temperature accelerated release testing of PLGA microspheres. J. Control. Release 2006, 112:293-300.
42. Faisant N., Akiki J., Siepmann F., Benoit J.P., Siepmann J. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory. Int. J. Pharm. 2006, 314:189-197.